Tag: drug pricing

Pharmaceutical Pricing: The Many Faces of Fairness

Panel Seeks To Define “Fair” Pharmaceutical Pricing  Barcelona, Spain—13 November 2018—ISPOR, the professional society for health economics and outcomes research, held its second plenary of ISPOR Europe 2018 this morning. The timely session, “Pharmaceutical Pricing: The Many Faces of Fairness,”

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

ISPOR Europe 2018 Conference to Focus on Improving Healthcare Systems in Europe

More Than 5000 Healthcare Stakeholders Will Convene on 10-14 November 2018 in Barcelona, Spain Lawrenceville, NJ, USA—October 30, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming ISPOR Europe

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

Plenary Sessions and Speakers Announced for ISPOR Europe 2018

Conference to Focus on Improving European Health Systems Scheduled for 10-14 November 2018 in Barcelona, Spain Lawrenceville, NJ, USA—September 24, 2018—ISPOR, the professional society for health economics and outcomes research, announced plenary sessions and speakers for ISPOR Europe 2018 that

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , ,

ISPOR Announces Keynote Speaker and Program for Upcoming Summit on Value Assessment and Healthcare Pricing

Mark McClellan, MD, PhD to Provide Keynote Address for October 19 Summit Lawrenceville, NJ, USA—September 4, 2018—ISPOR, the professional society for health economics and outcomes research, announced its program and speakers for the upcoming ISPOR Summit 2018, “New Approaches to

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR Announces New Summit on Value Assessment

Summit Scheduled for October 19, 2018 in Washington, DC, USA Lawrenceville, NJ, USA—June 26, 2018—ISPOR, the professional society for health economics and outcomes research, announced a new ISPOR Summit “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare”

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR Panel Discusses Recommendations and Rationale of “Making Medicines Affordable: A National Imperative”

Session Explores Strategies to Tackle Rising Costs of Prescription Drugs in the United States Without Discouraging Development Baltimore, MD, USA—May 22, 2018—ISPOR, the professional society for health economics and outcomes research, held a session, “‘Making Medicines Affordable: A National Imperative’—Reflections

Posted in Announcements, ISPOR News & Press Tagged with: , ,

New Drugs and Medical Technologies Often Deemed “Cost-Effective but Unaffordable”

Experts Offer Pragmatic Approaches to Managing Tension Between Affordability and Cost-Effectiveness Lawrenceville, NJ, USA—March 27, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , ,

Top 10 Trends Driving Healthcare in 2018

ISPOR Announces Influential Topics in Health Economics and Outcomes Research   Lawrenceville, NJ, USA—February 6, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the release of its “Top 10 HEOR Trends” list that identifies the

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , , , , , , , , ,

Orphan Drugs—Exploring the Challenges of Pricing, Reimbursement, and Funding

Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held several sessions on the topic of orphan drugs at its 20th Annual European Congress, currently being held 4-8 November 2017 in Glasgow, Scotland, UK.

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Short- and Long-Term Impact of Medicare Negotiating Drug Prices: A Critical Look at the Policy Proposals

Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted a session that explored the economic impact of Medicare directly negotiating drug prices for enrollees. The session was held this afternoon at ISPOR’s 22nd Annual International Meeting

Posted in Announcements, ISPOR News & Press Tagged with: , ,